Ultragenyx Pharmaceutical Inc.
NASDAQ:RAREBiotechnology
Healthcare
$17.22 +3.01%
+$0.81 today
- Market cap
- $1.76B
- Beta
- 0.38
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$6.06
52W Low $18.29High $42.37
Volume 3.12M
Average 1.81M
Price history
Ultragenyx Pharmaceutical Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-44.77%
Period high
$36.54
Period low
$12.88
Latest
$17.22
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 4, 2026 | Nov 3, 2026 | |
| 8-K | Nov 3, 2026 | Nov 3, 2026 | |
| SC 13G/A | Oct 30, 2026 | Oct 30, 2026 | |
| SC 13G | Oct 20, 2026 | Oct 20, 2026 | |
| 4 | Oct 19, 2026 | Oct 19, 2026 | |
| 8-K | Oct 19, 2026 | Oct 19, 2026 | |
| 8-K | Oct 14, 2026 | Oct 14, 2026 | |
| 8-K | Oct 7, 2026 | Oct 7, 2026 | |
| 8-K | Sep 17, 2026 | Sep 17, 2026 | |
| 4 | Sep 15, 2026 | Sep 15, 2026 | |
| 4 | Sep 8, 2026 | Sep 8, 2026 | |
| 8-K | Sep 2, 2026 | Sep 2, 2026 | |
| 8-K | Aug 19, 2026 | Aug 19, 2026 |
Competitors
Who does Ultragenyx Pharmaceutical Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about RARE's filings, answered from its disclosures.
What is the latest RARE filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does RARE have?
Intrinsic Alpha currently shows 20 recent filings for RARE.
Continue the stock analysis
Jump to another research area for this company.